• insomnia

    Extended Release Gabapentin (Neurontin) for Hot Flashes

    Several studies have shown that gabapentin (Neurontin) at 600-2400 mg/day in divided doses is effective for treating hot flashes in menopausal women.  Research presented at the annual meeting of the North American Menopause Society (NAMS) indicates that an investigational extended release (ER) formulation of gabapentin (Serada, Depomed) is effective for the treatment of hot flashes and sleep disturbance.

    New Research from the CWMH: Escitalopram and Sleep in Midlife Women with Vasomotor Symptoms

    Selective serotonin and serotonin-norepinephrine inhibitors (SSRIs and SNRIs) have been shown to be effective for the treatment of hot flashes.  However, these agents may carry certain side effects, including sexual side effects and sleep disturbance.  These two side effects may be particularly concerning to peri- and postmenopausal women who, in addition to having vasomotor symptoms, are more likely to experience sexual dysfunction and sleep disruption than premenopausal women.

    Insomnia Across the Female Life Cycle

    In the July 2010 issue of Current Psychiatry, you will find a thorough review on the evaluation and treatment of insomnia in women across the life cycle.  The bottom line is that many women experience insomnia during times of hormonal transition.  The authors provide some useful guidelines for evaluating women who present with sleep problems (taken from Table 2):

    Melatonin in Pregnancy: Is it Safe?

    Many women experience some degree of sleep disturbance during pregnancy. For a significant number of women, the sleep disruption may be so severe as to require some type of intervention. In a previous post, we discussed the use of different types of medications to treat insomnia during pregnancy. While these drugs are highly effective, many women with sleep problems inquire about the use of "natural" agents, such as melatonin, during pregnancy.

    Go to Top